4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001470831-26-000812
President and COO sold 18,750 shares at $27.98 ($524,533)
- President and COO acquired 18,750 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Cohlhepp Ryan · President and COO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-10 | Exercise or conversion : show line 1 in the form 10b5-1 | +18,750 | $3.79 | $71,059 | 200,391 | D |
| 2026-08-10 | Sale : show line 2 in the form 10b5-1 | −18,750 | $27.98 | $524,533 | 181,641 | D |
| Open-market sales · 18,750 sh · avg $27.98 · $524,533 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-10 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −18,750 | 51,752 | D |
Loading xslF345X06/wk-form4_1786565947.xml…